Diagnosis and Management of Aplastic Anemia
Aplastic anemia remains a diagnosis of exclusion. Our ability to reliably diagnose, and therefore exclude, a variety of
Aplastic anemia remains a diagnosis of exclusion. Our ability to reliably diagnose, and therefore exclude, a variety of
Autoimmune lymphoproliferative syndrome (ALPS) represents a failure of apoptotic mechanisms to maintain lymphocyte homeostasis, permitting accumulation of lymphoid
Guidelines on hereditary spherocytosis (HS) published in 2004 (Bolton-Maggs et al, 2004) are here replaced to reflect changes in current
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation, occurring as either a familial disorder or a
BLOOD, 13 OCTOBER 2011 , VOLUME 118, NUMBER 15
The purpose of this article is to set forth our approach to diagnosing and managing the
thalassemias, including b-thalassemia intermedia and
BLOOD, 11 AUGUST 2011 , VOLUME 118, NUMBER 6
Since 2004, a national observational study has been aiming to thoroughly describe cases and identify prognostic factors. Patients
The appropriate classification of hypoplastic BM disorders in young patients continues to be a great challenge. Accurate diagnosis
The guideline writing group was selected to be representative of UK-based medical experts.
doi:10.1111/j.1365-2141.2011.08793.x British Journal of Haematology, 155,
נותנות החסות לאיגוד: